Your browser doesn't support javascript.
loading
Long-term abatacept treatment for 48 weeks in patients with primary Sjögren's syndrome: The open-label extension phase of the ASAP-III trial.
de Wolff, Liseth; van Nimwegen, Jolien F; Mossel, Esther; van Zuiden, Greetje S; Stel, Alja J; Majoor, Kalle I; Olie, Lisette; Los, Leonoor I; Vissink, Arjan; Spijkervet, Fred K L; Verstappen, Gwenny M P J; Kroese, Frans G M; Arends, Suzanne; Bootsma, Hendrika.
Afiliação
  • de Wolff L; Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Centre Groningen, Groningen, the Netherlands.
  • van Nimwegen JF; Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Centre Groningen, Groningen, the Netherlands.
  • Mossel E; Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Centre Groningen, Groningen, the Netherlands.
  • van Zuiden GS; Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Centre Groningen, Groningen, the Netherlands.
  • Stel AJ; Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Centre Groningen, Groningen, the Netherlands.
  • Majoor KI; Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Centre Groningen, Groningen, the Netherlands.
  • Olie L; Department of Ophthalmology, University of Groningen, University Medical Centre Groningen, Groningen, the Netherlands.
  • Los LI; Department of Ophthalmology, University of Groningen, University Medical Centre Groningen, Groningen, the Netherlands.
  • Vissink A; Department of Oral and Maxillofacial Surgery, University of Groningen, University Medical Centre Groningen, Groningen, the Netherlands.
  • Spijkervet FKL; Department of Oral and Maxillofacial Surgery, University of Groningen, University Medical Centre Groningen, Groningen, the Netherlands.
  • Verstappen GMPJ; Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Centre Groningen, Groningen, the Netherlands.
  • Kroese FGM; Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Centre Groningen, Groningen, the Netherlands.
  • Arends S; Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Centre Groningen, Groningen, the Netherlands.
  • Bootsma H; Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Centre Groningen, Groningen, the Netherlands. Electronic address: h.bootsma@umcg.nl.
Semin Arthritis Rheum ; 53: 151955, 2022 04.
Article em En | MEDLINE | ID: mdl-35091325
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndrome de Sjogren Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Semin Arthritis Rheum Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndrome de Sjogren Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Semin Arthritis Rheum Ano de publicação: 2022 Tipo de documento: Article